Back to search

Article

Muscular dystrophy cell therapy : an in utero approach using human fetal mesenchymal stem cells

2009-01-01

Abstract excerpt

Duchenne muscular dystrophy (DMD) is the most prevalent genetic neuromuscular disorder and affects 1 in 3,500 live male births. Lack of the protein dystrophin in muscle fibres causes permanent muscle damage, is lethal and despite various potential therapeutic strategies aimed at restoring dystrophin expression, has no cure. As DMD affects all skeletal muscles as well as the heart, a systemic treatment would be nec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b51ab7dc-c434-5e00-a181-3dc66b1127b4
DOI
10.25560/4726
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Muscular dystrophy cell therapy : an in utero approach using human fetal mesenchymal stem cellsDOI 10.25560/4726
Select a neighboring publication to make it the new centre.